Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

Plus, news about Convergent Therapeutics, Turnstone Biologics and Sonnet BioTherapeutics:

Lyra Therapeutics pauses development of chronic rhinosinusitis drug: The company

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Daré’s royalty deal; Qlaris Bio raises $24M

Plus, news about Newron and SynOx: Daré Bioscience inks royalty deal with XOMA: The company received $22 million, which is expected to help progress a

May 1, 2024

Beacon Biosignals receives FDA clearance for sleep tracking headband

Dive Brief: Beacon Biosignals received U.S. Food and Drug Administration clearance for its sleep monitoring headband. Beacon’s at-home device, the Dreem 3S, features six electroencephalogram (EEG)

September 18, 2023

Marketing payments to cancer doctors lead to more prescriptions but not better outcomes, NBER paper finds

Cancer drugmakers’ marketing payments to physicians do work, but they don’t improve patient mortality, according to a new National Bureau of Economic Research working paper.

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.